Skip to content
Screener

Heartflow, Inc. HTFL Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

HTF
Heartflow, Inc.HTFL
$95.5K+35.9%
TRV
Trevi Therapeutics, Inc.TRVI
$295.25K+5.8%
Albany International Inc. logo
Albany International Inc.AIN
$251K
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$527.25K-81.4%
AVN
AVNSAVNS
$375K

Other financials

Income statement

See full
Revenue$52.6M+41.3%
Gross profit$42.2M+50.9%
Operating income-$29.5M-68.6%
Net income-$27.4M+15.4%
EPS (diluted)-$0.32+93.9%

Balance sheet

See full
Cash & equivalents$24.4M-78.7%
Total debt$26.3M
Total equity$285.7M+132%
Total assets$344.0M

Cash flow

See full
Operating cash flow-$30.1M-129%
CapEx$1.9M+71.6%
Free cash flow-$32.0M-124%

Valuation

See full
Market cap$2.34B-3.7%
Enterprise value$2.35B
P/S12.3×

Profitability

See full
Gross margin78.1%+2.4pp
Operating margin-39.7%-4.8pp
Net margin-58.4%-12.1pp
FCF margin-40.1%-2.4pp

Returns & leverage

See full
Return on equity37.1%
Debt / equity0.1×
Current ratio5.6×

Where this comes from

Reported directly by Heartflow, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The source filing: Heartflow, Inc.’s 10-K, filed March 18, 2026.

Filed
Mar 18, 2026, 12:00 AM EDT
Fiscal year
FY2025
Accession
0001464521-26-000042
Line itemAmountPercentage
U.S. federal statutory rate$(24,542)21.0%
Foreign tax effects1,201-1.0%
Tax credits:
R&D credits(382)0.3%
Change in valuation allowance6,316-5.4%
Nontaxable or nondeductible items:
Write-off of intercompany payable4,759-4.1%
Mark-to-market on warrant and derivative7,683-6.5%

Item 8. Financial Statements and Supplementary Data

FAQ

What is Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
Heartflow, Inc. (HTFL) reported effective income tax rate reconciliation, tax credit, research, amount of $95.5K in Q4 2025.
How has Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount increased by 35.9% year-over-year, from $70.25K to $95.5K.
What is the long-term trend for Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
Over 2 years (2023 to 2025), Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount has grown at a -1.2% compound annual growth rate (CAGR), from $391K to $382K.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
Represents the total dollar value of research and development tax credits applied to reduce income tax liability. It indicates the extent to which the company leverages government incentives to offset R&D investment costs.

Ask your AI about Heartflow, Inc.'s effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude